Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide

Neurochemistry International

Volumn 50, Issue 4, 2007, Pages 671-680

  Zhu, Yuangui ^a,b   Carvey, Paul M ^a   Ling, Zaodung ^a,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Dopamine; Glutathione; Lipopolysaccharide; Parkinson's disease; Prenatal

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LIPID PEROXIDE; LIPOPOLYSACCHARIDE; PROTEIN SUBUNIT;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; FEMALE; HOMEOSTASIS; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SUBSTANTIA NIGRA;

AGING; ANIMALS; ANIMALS, NEWBORN; CAUSALITY; CELL DEATH; DOPAMINE; ENCEPHALITIS; ENZYME ACTIVATION; FEMALE; GLUTATHIONE; HOMEOSTASIS; INFLAMMATION MEDIATORS; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; MALE; NERVE DEGENERATION; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS;

EID: 33847304640     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.12.013     Document Type: Article

References (30)

1. Ahmad M., Yousuf S., Khan M.B., Hoda M.N., Ahmad A.S., Ansari M.A., Ishrat T., Agrawal A.K., and Islam F. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacol. Biochem. Behav. 83 (2006) 150-160
2. Arimoto T., and Bing G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol. Dis. 12 (2003) 35-45
3. Bharath S., Hsu M., Kaur D., Rajagopalan S., and Andersen J.K. Glutathione, iron and Parkinson's disease. Biochem. Pharmacol. 64 (2002) 1037-1048
4. Board P., Coggan M., Johnston P., Ross V., Suzuki T., and Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol. Ther. 48 (1990) 357-369
5. Castano A., Herrera A.J., Cano J., and Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J. Neurochem. 70 (1998) 1584-1592
6. Cory-Slechta D.A., Thiruchelvam M., Barlow B.K., and Richfield E.K. Developmental pesticide models of the Parkinson disease phenotype. Environ. Health Perspect. 113 (2005) 1263-1270
7. Dringen R., Gutterer J.M., and Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267 (2000) 4912-4916
8. Fishell G., and van der Kooy D. Pattern formation in the striatum: developmental changes in the distribution of striatonigral projections. Brain Res. Dev. Brain Res. 45 (1989) 239-255
9. Forman H.J., Shi M.M., Iwamoto T., Liu R.M., and Robison T.W. Measurement of gamma-glutamyl transpeptidase and gamma-glutamylcysteine synthetase activities in cells. Methods Enzymol. 252 (1995) 66-71
10. Gao H.M., Jiang J., Wilson B., Zhang W., Hong J.S., and Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81 (2002) 1285-1297
11. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106 (1980) 207-212
12. Griffith O.W., Bridges R.J., and Meister A. Evidence that the gamma-glutamyl cycle functions in vivo using intracellular glutathione: effects of amino acids and selective inhibition of enzymes. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 5405-5408
13. Herrera A.J., Castano A., Venero J.L., Cano J., and Machado A. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol. Dis. 7 (2000) 429-447
14. Iravani M.M., Leung C.C., Sadeghian M., Haddon C.O., Rose S., and Jenner P. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Eur. J. Neurosci. 22 (2005) 317-330
15. Kenchappa R.S., and Ravindranath V. Gamma-glutamyl cysteine synthetase is up-regulated during recovery of brain mitochondrial complex I following neurotoxic insult in mice. Neurosci. Lett. 350 (2003) 51-55
16. Ling Z., Chang Q.A., Tong C.W., Leurgans S.E., Lipton J.W., and Carvey P.M. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp. Neurol. 190 (2004) 373-383
17. Ling Z., Zhu Y., Tong C., Snyder J.A., Lipton J.W., and Carvey P.M. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp. Neurol. 199 (2006) 499-512
18. Ling Z., Gayle D.A., Ma S.Y., Lipton J.W., Tong C.W., Hong J.S., and Carvey P.M. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov. Disord. 17 (2002) 116-124
19. Ling Z.D., Chang Q., Lipton J.W., Tong C.W., Landers T.M., and Carvey P.M. Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience 124 (2004) 619-628
20. Liu R.M. Down-regulation of gamma-glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging. J. Neurosci. Res. 68 (2002) 344-351
21. Liu R.M., Gao L., Choi J., and Forman H.J. Gamma-glutamylcysteine synthetase: mRNA stabilization and independent subunit transcription by 4-hydroxy-2-nonenal. Am. J. Physiol. 275 (1998) L861-L869
22. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 263 (1988) 17205-17208
23. Mihaljevic B., Katusin-Razem B., and Razem D. The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic. Biol. Med. 21 (1996) 53-63
24. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., and Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36 (1994) 348-355
25. Theodore C., Singh S.V., Hong T.D., and Awasthi Y.C. Glutathione S-transferases of human brain. Biochem. J. 225 (1985) 375-382
26. Thiruchelvam M., Prokopenko O., Cory-Slechta D.A., Richfield E.K., Buckley B., and Mirochnitchenko O. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J. Biol. Chem. 280 (2005) 22530-22539
27. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27 (1969) 502-522
28. White C.C., Viernes H., Krejsa C.M., Botta D., and Kavanagh T.J. Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Anal. Biochem. 318 (2003) 175-180
29. Williams A.C., and Ramsden D.B. Autotoxicity, methylation and a road to the prevention of Parkinson's disease. J. Clin. Neurosci. 12 (2005) 6-11
30. Zhu Y., Carvey P.M., and Ling Z. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res. 1090 (2006) 35-44